[1]
I. Lisni, K. . Lestari, and L. R. Andalusia, “Polypharmacy in Type 2 Diabetes Patients of the PROLANIS Program in Indonesia: Identification of Potential Drug-Drug Interaction ”, Jordan j. pharm. sci., vol. 18, no. 1, pp. 245–257, Mar. 2025.